Your browser doesn't support javascript.
loading
Effects of exenatide once weekly plus dapagliflozin, exenatide once weekly alone, or dapagliflozin alone added to metformin monotherapy in subgroups of patients with type 2 diabetes in the DURATION-8 randomized controlled trial.
Frías, Juan P; Hardy, Elise; Ahmed, Azazuddin; Öhman, Peter; Jabbour, Serge; Wang, Hui; Guja, Cristian.
Afiliação
  • Frías JP; National Research Institute, Los Angeles, California.
  • Hardy E; AstraZeneca, Gaithersburg, Maryland.
  • Ahmed A; Apex Medical Research, Chicago, Illinois.
  • Öhman P; AstraZeneca, Gaithersburg, Maryland.
  • Jabbour S; Division of Endocrinology, Diabetes and Metabolic Diseases, Sidney Kimmel Medical College of Thomas Jefferson University, Philadelphia, Pennsylvania.
  • Wang H; AstraZeneca, Gaithersburg, Maryland.
  • Guja C; Department of Diabetes, Nutrition and Metabolic Diseases, Carol Davila University of Medicine and Pharmacy, Bucharest, Romania.
Diabetes Obes Metab ; 20(6): 1520-1525, 2018 06.
Article em En | MEDLINE | ID: mdl-29573139
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Compostos Benzidrílicos / Diabetes Mellitus Tipo 2 / Exenatida / Glucosídeos / Hipoglicemiantes / Metformina Tipo de estudo: Clinical_trials Limite: Adult / Aged / Humans / Middle aged Idioma: En Ano de publicação: 2018 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Compostos Benzidrílicos / Diabetes Mellitus Tipo 2 / Exenatida / Glucosídeos / Hipoglicemiantes / Metformina Tipo de estudo: Clinical_trials Limite: Adult / Aged / Humans / Middle aged Idioma: En Ano de publicação: 2018 Tipo de documento: Article